Biotech Business Week articles from November 2003

Biotech Business Week archives from November 2003

EnSite NavX released for visualization of heart chambers.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Endocardial Solutions, Inc., (ECSI) announced the release of the next version of its EnSite NavX intracardiac non-fluoroscopic navigation system. EnSite NavX, which was first released in May of this...

Research collaboration studies 2,000 full-length human cDNA clones.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- OriGene Technologies, Inc., announced a research collaboration with Tanox, Inc., (TNOX) for the functional study of 2,000 full-length human cDNA clones encoding membrane bound proteins. Tanox will...

Amersham acquisition complete; transaction worth $9.5 billion.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- General Electric Co. (GE) and Amersham, plc, announced that, subject to regulatory approval and other customary conditions, they have reached agreement on the terms of an all stock transaction whereby...

GE completes acquisition of Finnish company.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- General Electric Co. (GE), through its GE medical systems division, completed the acquisition of Finland-based Instrumentarium. "Both companies have long track records of technology innovation. The...

FDA panel considers postmenopausal estrogen plus progestin.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) met recently to discuss the use of Wyeth's estrogen plus progestin (E+P) hormone therapy...

M3 antagonist on track for 2004 launch.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corporation has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Enablex (darifenacin hydrobromide) for the treatment of overactive bladder....

New device-based skin treatments reported.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Device-based acne treatments are rapidly finding acceptance from physicians and patients, according to clinical news reports in the most recent issue of the Aesthetic Buyers Guide, published by Medical...

Tri-Nasal Nasal Spray acquired from Muro Pharmaceutical.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Collegium Pharmaceutical, Inc., a closely held specialty pharmaceutical company, announced that it has acquired from Muro Pharmaceutical, Inc., all rights to Tri-Nasal (triamcinolone acetonide, USP)...

Avoiding pets may not prevent allergies.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Exposure to high levels of cat allergen as a child may prevent the development of allergies, according to a study published in the Journal of Allergy and Clinical Immunology (JACI). Researchers...

Biologic marker specific for the diagnosis of Alzheimer disease.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Berlex Pharmaceuticals, a U.S. affiliate of Schering AG Germany (SHR), announced that it has discovered that a receptor protein molecule, CCR1, that is usually found on the surface of white blood cells...

Research program funded for study of RNAi technology in ALS.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- CytRx Corporation (CYTR) announced that it has agreed to fund a sponsored research program at the University of Massachusetts Medical School (UMMS) for the use of RNAi gene silencing technology in the...

Update provided on FDA review of PMR System.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- CardioGenesis Corporation (CGCP), a provider of angina-relieving Transmyocardial Revascularization (TMR) and percutaneous myocardial revascularization (PMR), announced that the company and the U.S. Food...

Rheumatoid arthritis treatment studied in phase II trial.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Regeneron Pharmaceuticals, Inc., (REGN) announced that the company's IL-1 Trap demonstrated evidence of efficacy and safety in patients with rheumatoid arthritis (RA) in a phase II dose-ranging study in...

Technology licensed to accelerate development of model-based assays.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- The BioAnalytics Group, LLC, has completed an agreement to license technology from Predix Pharmaceuticals Holdings, Inc., to accelerate the development of its model-based assays technology. ...

Phase II study initiated to evaluate recombinant alpha 1-antitrypsin gel.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences (TSX: PLI) and Arriva Pharmaceuticals, Inc., announced that their joint venture company, Arriva-ProMetic, Inc., (JV), has opened a phase II clinical study to evaluate its lead...

Two phase IIa trials initiated in dermatology.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Encysive Pharmaceuticals (ENCY) announced that its majority-owned German affiliate, Revotar Biopharmaceuticals AG, initiated two double-blind, placebo, and standard drug controlled phase IIa clinical...

Soft-patch device used to close hole in heart of pediatric patient.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Without performing surgery, a physician at Advocate Hope Children's Hospital in Oak Lawn, Illinois, has used a special instrument successfully to patch a hole in the heart wall of an infant. The child...

Services launched for biorepository management.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Ardais Corporation announced the availability of its Biomaterials and Information for Genomic Research (BIGR) Biospecimen Management System (BMS), a comprehensive set of services and licenses that...

Tissue to be used to determine genetic cause of cancer.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Asterand, the Detroit-based human tissue bank, is re-examining research materials and data donated over 30 years ago for new clues to the genetic causes of breast cancer. "October is breast cancer...

Rights acquired for use of compound with broad surgical applications.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- BTG (BGC) announced that it has acquired the exclusive rights for the development of MESNA (sodium-2-mercaptoethane sulfonate) as a chemical dissection agent for surgical applications of all types. ...

Biotech-based anticancer therapies becoming more prevalent.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- New figures released today by Pharmaprojects show that a quarter of all anti-cancer therapies in development are based on biotechnology. Pharmaprojects analyzed the number of biotechnology products...

MDdatacor hits milestone, with 2 million cardiology patients in database.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- MDdatacor, inc., announced at Barnett International's eighth annual Strategies to Maximize Patient Recruitment Conference that it has accumulated longitudinal medical data for more than 2 million...

NIH grant to be used for development of stem cell treatment.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that it has received a $100,000 Phase I Small Business Innovation Research grant from the U.S. National Institutes of Health (NIH) to develop a bone marrow...

Advanced genomic technologies used as focus of alliance.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cenetron Diagnostics, Ltd., a leading provider of molecular diagnostic services, announced it has signed a 5-year strategic alliance agreement with Roche Diagnostics to establish itself as a Molecular...

Alliance to develop RNAi compounds, gene regulation research.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced that CombiMatrix is collaborating with researchers at the Seattle Biomedical Research Institute (SBRI). The collaboration was formed to conduct a...

Alliance to expand immunoassay portfolio.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., (BEC) announced that they have entered into an agreement with R&D Systems, a wholly owned subsidiary of Techne Corporation (TECH). Effective immediately, the non-exclusive,...

Alliance to focus on discovery of new biomarkers of inflammatory disease.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- BioVisioN AG, Hannover, and the international pharmaceutical company AstraZeneca have signed a collaboration agreement. The collaboration will focus on the discovery of new biomarkers of...

Alliance will focus on infectious, parasitic disease research.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Invest U.K., the British government's worldwide inward investment agency, announced that the U.S. Centers for Disease Control and Prevention (CDC) has signed a formal memorandum of understanding with...

Amended agreement signed to sell Eligix HDM System.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- BioTransplant, Inc., announced that it has entered into an amended agreement relating to the sale of its Eligix HDM Cell Separation System to Miltenyi Biotec GmbH. Because certain of the biological...

Commercialization agreement signed for home nebulizer.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Aerogen, Inc., (AEGN) and Medical Industries America, Inc., (MIA) announced that they have entered into an agreement for manufacturing and marketing of the Aeroneb Go Nebulizer (Aeroneb Go), which...

Company alliance targets development of new transfection technology.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Swedish biotech tools company Cellectricon announced that it has licensed Axon Instruments (Union City, California) to have sole access to Cellectricon's patented electroporation technology. Under...

Gene regulation database licensed.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cognia Corporation, developers and distributors of information products for drug discovery, announced that research groups at Pfizer, Inc., and Chiron, Inc., licensed Transfac Professional. ...

Promotion agreement signed with Baxter for vaccine manufacturing services.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Althea Technologies, Inc., a provider of gene-based manufacturing and testing services to accelerate drug development, announced that it has entered into an agreement with Baxter Healthcare Corporation...

Research to assess factors affecting siRNA for gene silencing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Dharmacon, Inc., a supplier of RNA and RNA interference (RNAi) research products, announced that it has entered into a collaboration with Rosetta Inpharmatics, LLC, a wholly owned subsidiary of Merck &...

Fecal immunochemical test improves colorectal cancer screening.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Enterix Inc. announced that its InSure Fecal Immunochemical Test (FIT) significantly improved patient participation in colorectal cancer screening compared with Hemoccult, a traditional guaiac fecal...

Chemistry-driven drug discovery company changes name.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- ChemCodes, Inc., announced its name change to Nuada Pharmaceuticals, Inc. This change is part of the overall plan of realigning of its business mission and growth to focus on discovery of small...

FemOne announces name change, new symbol.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- FemOne, Inc., (FEMOV), formerly New Paltz Capital Corp. (NPZC), a Carlsbad, California-based, direct selling nutrition, skincare, and cosmetics company with distribution in the United States and Canada,...

Crohn disease drug therapies will nearly double to $1.2 billion in 2012.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., finds that sales of Crohn disease (CD) drug therapies will increase from $713 million in 2002 to nearly $1.2 billion in 2012. According to a new Pharmacor study entitled...

FDA approves new spinal implant device.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Encore Medical Corporation (ENMC) announced that its Surgical Division received approval from the U.S. Food and Drug Administration (FDA) for its Cyclone Anterior Cervical Plate. The Cyclone addresses...

Human Epigenome Project to follow E.U.-pilot study.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Epigenomics AG and The Wellcome Trust Sanger Institute announced an agreement to fund and carry out the first phase of the Human Epigenome Project (HEP). The HEP will identify and describe sites in...

Noveon expands thermoplastic-urethane product line.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Noveon has purchased certain assets of Thermedics Polymer (Thermedics), a manufacturer of thermoplastic polyurethane (TPU), from VIASYS Healthcare, Inc. This acquisition will expand Noveon's Estane...

Three-year pact signed for congestive heart failure patient management.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- American Healthways, Inc., (AMHC) announced the signing of a 3-year agreement with Horizon Healthcare Services, Inc., and its subsidiary, Horizon Healthcare of New Jersey, Inc., (Horizon) to provide the...

Moore Medical obtains rights to distribute medical products.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Moore Medical Corp. (MMD) has obtained the rights to distribute Midmark Corp.'s line of medical products, including power and manual exam tables, specialty tables and chairs, sterilizers, diagnostic...

Agreement to sell gastrointestinal products signed.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Aventis announced it has agreed to sell Axcan Pharma, Inc., the North American rights to three Aventis gastrointestinal products. Under the terms of the agreement, Axcan will acquire Carafate and...

BioMEMS maker and MicroCHIPS expand strategic R&D partnership.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Micralyne, Inc., and MicroCHIPS, Inc., announced that they have expanded the scope of their work together for the development of MicroCHIPS' innovative drug-delivery and biosensing devices. ...

Rights acquired to new aerosol inhalation device.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Bayer Biological Products (BP) announced the signing of a deal with Inamed GmbH (Gemuenden, Germany) for exclusive use of its new advanced inhalation technology for the dosing of alpha-1 antitrypsin...

Software upgrade enables compound identification prior to manufacturing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Simulations Plus, Inc., (SIMU) is releasing QMPRPlus software, version 4.0, which predicts a number of critical properties of molecules from just their molecular structure. "QMPRPlus (Quantitative...

Pharmaceutical company developing products to fight E. coli contamination.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NYMX) is taking two approaches to address the serious public health problem posed by the contamination of meat and other food and drink products by potentially deadly...

Palm Beach County approves $200 million in bonds to lure biotech.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Although Scripps Research Institute chose Palm Beach County, Florida, as the site to build its second biomedical research facility, all of Florida also will reap the dividends, representatives of...

Biotech firm engages provider of investment banking services.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- American Oriental Bioengineering, Inc., (AOBO) announced that the company has engaged Westminster Securities Corporation to provide investment banking services. Westminster Securities will assist...

Biotech firm raises $56M in series B financing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CTI), a private biopharmaceutical company that discovers and develops novel therapies for critical care medicine, announced it has closed a $56 million Series B financing....

Cancer vaccine company completes UKP 17M financing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- BioVex, Ltd., announced the completion of a UKP 17 million (U.S. $28 million) private placement. The placement was led by Scottish Equity Partners (U.K.). Other new investors participating in the...

Hearing-aid company completes $2 million financing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- HearUSA, Inc., (EAR) has completed a private placement of $2 million of unsecured notes with a number of investors, including three of HearUSA's directors. The 1-year notes bear interest at a rate...

Immune system therapy developer announces conversion of debt.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corp. (CVM) announced that all of the remaining outstanding debentures from its debt financing with two institutional investors have been converted into shares of Cel-Sci common stock. This...

Medical device company secures $26 million in third round of financing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- OmniSonics Medical Technologies closed a round of financing totaling $26 million from top-tier venture capital firms. Led by Connecticut-based new investor GE Asset Management, the Series C round...

Oncology company's resale registration statement declared effective by SEC.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO), a product driven, oncology-focused biopharmaceutical company, announced that the U.S. Securities and Exchange Commission (SEC) has declared effective the resale registration...

Pharmaceutical company amends guidance based on merger activity.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cima-Labs, Inc., announced that it is updating its guidance for the third quarter and full year 2003. Third-quarter revenues are expected to be within the company's previously announced guidance...

Pharmaceutical company amends stockholders agreement.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Arena Pharmaceuticals, Inc., (ARNA) announced that the stockholders agreement dated as of January 17, 2003, with its largest stockholder, Biotechnology Value Fund, L.P. and certain related entities...

Pharmaceutical company announces public offering of 5.6M shares.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced its intention to publicly offer 5.6 million shares of its common stock pursuant to its effective "shelf" registration statement previously filed with the...

Pharmaceutical company anticipates stronger-than-expected third quarter.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BDY) announced that it anticipates earnings per diluted share for the third quarter 2003 will meet or exceed a range of $0.34 to $0.36, an approximately 17% to 24%...

Pharmaceutical company completes $40.5M financing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (AKRN) announced that it has completed its $40.5 million financing. On September 25, 2003, the company announced that it had entered into a preferred stock and note purchase agreement...

Pharmaceutical company secures $57M in a senior credit facility.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- ESP Pharma, Inc., announced that it has closed a $57 million senior credit facility with a syndicate of lenders. This, in combination with prior Series A and B funding rounds, represents an...

Pharmaceutical company sells common stock.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- CollaGenex Pharmaceuticals, Inc., (CGPI) announced that Marquette Venture Partners II, L.P., and OCM Principal Opportunities Fund, L.P., have separately entered into agreements with certain...

Pharmaceutical firm developing wound healing gel announces $2.5M investments.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cytomedix, Inc., (CYME) announced that it has closed a private offering of its common stock. The private offering generated $2,499,000 in gross proceeds. The proceeds of the offering will be used...

Pharmaceutical firm prices IPO.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Acusphere, Inc., (ACUS) announced the pricing of its initial public offering of 3,750,000 shares of its common stock at $14.00 per share, before underwriting discounts and commissions. The offering...

Vaccine maker files shelf registration statement for 15M shares.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics, Inc., (AVAN) announced the filing of a shelf registration on Form S-3 with the U.S. Securities and Exchange Commission (SEC). Once declared effective by the SEC, the shelf...

Drug discovery company raises $15 million in first close of equity financing.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Nuevolution A/S has raised US$15 million in the first closing of a series B equity financing. This second round of financing was led by Scandinavian Life Science Venture, and brings to US$24...

Bone growth stimulation business bought for $93 million in cash.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- dj Orthopedics, Inc., (DJO) has signed a definitive agreement to purchase the bone growth stimulation (BGS) business from OrthoLogic Corporation (OLGC) for $93 million in cash, subject to the approval...

Company receives grant to develop technologies for gene expression profiling.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- NuGEN Technologies, Inc., has received a phase I Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH) to support the further development of its SPIA and...

Genetics company awarded $5.3 million for next phase of Human Genome Project.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Regulome Corporation will receive $5.3 million in funding under the National Human Genome Research Institute (NHGRI) ENCODE project, which aims to lay the foundation for the next phase of the Human...

Violent protests erupting over biotechnology.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- A growing militant movement opposed to genetic engineering in agriculture and medicine is turning to violent and criminal sabotage - from the bombing of a San Francisco Bay Area biotech company to the...

Companies form research collaboration to develop novel high-content drug screens.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cellular Genomics, Inc., (CGI), a chemical genetics based biopharmaceutical company, announced that it has established a research collaboration with Affymetrix, Inc. In the collaboration, CGI will...

Agreement terminated with Amersham.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, announced that the company had terminated a distribution and licensing agreement with Amersham...

Data released for 120,000 validated SNPs into public domain.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) released genotype data for 120,000 validated single nucleotide polymorphisms (SNPs) selected from both public SNP databases and the proprietary SNP database developed by...

China clinical trials completed for antibody tests.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (CYPT), the developer and marketer of the only two U.S. Food and Drug Administration (FDA) approved HIV-1 antibody tests that can be used on urine samples, as well as an...

MedPointe expands sales force to, among other duties, promote ZOMIG.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- MedPointe, Inc., has created three new sales forces and is in the process of recruiting 260 additional experienced pharmaceutical-sales representatives. The company is on track to fully staff these...

Feasibility phase of trials for CABG expanded.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) announced that it is expanding the number of hospitals and clinical investigators participating in the feasibility phase of its clinical trial for its patented...

Healthcare plan educates members about proton-pump inhibitors.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- As part of a long-standing commitment to educating its members and helping them maximize available benefits, Aetna will provide approximately 100,000 pharmacy members with educational information about...

Not approvable letter issued for Helicide.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., has announced that the U.S. Food and Drug Administration (FDA) has determined that the New Drug Application (NDA) that Axcan re-submitted for Helicide for the eradication of...

Pharmaceutical company files for GM-CSF approval in Canada.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Cangene Corporation (CNJ) announced that it has filed a Canadian New Drug Submission for Leucotropin, a protein known as GM-CSF. The submission seeks approval from the Biologics and Genetic...

Adjuvant licensed for the development of HIV vaccine.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- The Immune Response Corporation (IMNR) and Hybridon, Inc., (HYBN) have entered into a license agreement for the use of Amplivax as an adjuvant in the development of a novel vaccine candidate for the...

Combination hormone therapy does not benefit patients.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Combining two hormone therapies to treat the psychological effects of hypothyroidism may not be more effective than using a single therapy, according to new research articles published in the Journal of...

Orphan drug status granted for OGP.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- The Committee for Orphan Medicinal Products (COMP) adopted a positive opinion on the designation of the product OGP (10-14)L (H-Tyrosine-Glycine-Phenilalanine-Glycine-Glycine-OH) as an orphan drug for...

Molecular Imaging enters strategic alliance.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Molecular Imaging Corp. (MLRI), a provider of molecular-imaging (MI) services to healthcare entities in the U.S., has signed a strategic-alliance agreement with Siemens Medical Solutions, headquartered...